Newsletter Archives

Showing 281 to 300 of 927 articles.

MBE em foco - Volume 6, Issue 11

Tiazidas e câncer de pele? Não se deixe queimar pela hype.

EBM Focus - Volume 15, Issue 25

Azithromycin and propensity for death: side effect or sicker patients?

MBE em foco - Volume 6, Issue 10

Repetindo: vacina tríplice viral não aumenta o risco de autismo, mesmo entre crianças de alto risco

EBM Focus - Volume 15, Issue 24

Limited data show limited evidence of harm with gender-affirming hormone therapy for transgender individuals

EBM Focus - Volume 15, Issue 23

Does consuming organic foods really reduce your cancer risk?

Resident Focus - Volume 15, Issue 7

Subthreshold aerobic exercise shortens time to recovery compared to stretching in adolescents with sport-related concussion

EBM Focus - Volume 15, Issue 22

Black patients may be at increased risk of COVID-19 hospitalization and death

MBE em foco - Volume 6, Issue 9

Enfiando a agulha: tPA para AVC ao despertar, ou administrado mais de 4,5 horas após o início dos sintomas, pode melhorar a funcionalidade a 90 dias

EBM Focus - Volume 15, Issue 21

Workplace wellness programs appear to have little effect on health outcomes of benefits-eligible employees

EBM Focus - Volume 15, Issue 20

Early data promising: Remdesivir for COVID-19 may speed time to recovery but mortality benefit is uncertain

EBM Focus - Volume 15, Issue 19

Hold the knife - are antibiotics a reasonable option for pediatric appendicitis?

MBE em foco - Volume 6, Issue 8

Opiniões de especialistas e evidências de baixa qualidade ainda direcionam a maioria das recomendações fortes em cardiologia

Resident Focus - Volume 15, Issue 6

Intimate partner violence during pregnancy may increase risk of infant perinatal death

EBM Focus - Volume 15, Issue 18

Convalescent plasma therapy for COVID-19: Hope or hype?

Resident Focus - Volume 15, Issue 5

Sacubitril/valsartan might be associated with reduced risk of cardiovascular mortality or hospitalization for heart failure compared to valsartan alone in adults with heart failure with mid-range ejection fraction (45%-57%)

MBE em foco - Volume 6, Issue 7

Não são os inibidores da ECA que estão matando as pessoas com COVID-19

EBM Focus - Volume 15, Issue 17

Surrogate markers in pregnancy: should we adopt new guidance suggesting cesarean delivery for HSV in the third trimester?

EBM Focus - Volume 15, Issue 16

It’s not the ACE inhibitors that are killing people with COVID-19

MBE em foco - Volume 6, Issue 6

Canagliflozina para proteção renal: não é um novo inibidor da ECA

EBM Focus - Volume 15, Issue 15

CPAP doesn’t improve outcomes in patients with ACS and OSA, especially if they don’t use it